The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy

Cited by (1,000)

Items 301–400 of 1,000

1. The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies
   Ciliang Guo, Lingkai Kong, Lingjun Xiao, Kua Liu, Huawei Cui, Qilei Xin, Xiaosong Gu, Chunping Jiang, Junhua Wu · 2023 · Cell & Bioscience
2. Roles of the gut microbiota in immune-related adverse events: mechanisms and therapeutic intervention
   Yaqi Gao, Yong-Jie Tan, Jing‐Yuan Fang · 2025 · Nature Reviews Clinical Oncology
3. Gut microbiota targeted nanomedicine for cancer therapy: Challenges and future considerations
   Muhammad Shahid Riaz Rajoka, Hafiza Mahreen Mehwish, Yongai Xiong, Xun Song, Nazim Hussain, Qinchang Zhu, Zhendan He · 2020 · Trends in Food Science & Technology
4. N 6 -methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction
   Jinming Li, Lei Liang, Yongzhi Peter Yang, Xinxiang Li, Yanlei Ma · 2021 · Theranostics
5. Prior antibiotic administration disrupts anti-PD-1 responses in advanced gastric cancer by altering the gut microbiome and systemic immune response
   Kim, Chang Gon, Koh, June-Young, Shin, Su-Jin, Shin, Ji-Hee, Hong, Moonki, Chung, Hyun Cheol, Rha, Sun Young, Kim, Hyo Song, Lee, Choong-Kun, Lee, Ji Hyun et al. · 2023 · Cell Reports Medicine
6. Effects of Dietary Interventions on Gut Microbiota in Humans and the Possible Impacts of Foods on Patients’ Responses to Cancer Immunotherapy
   Li‐Shu Wang, Yue Yang Mo, Yi‐Wen Huang, Carla Elena Echeveste, Hsin‐Tzu Wang, Jiali Chen, Kiyoko Oshima, Martha Yearsley, Jesús Simal‐Gándara, Maurizio Antonio Battino et al. · 2020 · eFood
7. Oral Microbiota from Periodontitis Promote Oral Squamous Cell Carcinoma Development via γδ T Cell Activation
   Wei Wei, Jia Li, Xin Shen, Jinglu Lyu, Caixia Yan, Boyu Tang, Wenjuan Ma, Huixu Xie, Леи Жао, Lei Cheng et al. · 2022 · mSystems
8. Immunotherapy resistance in solid tumors: mechanisms and potential solutions
   Daniel S. Lefler, Steven Anthony Manobianco, Babar Bashir · 2024 · Cancer Biology & Therapy
9. Microbiome Integrity Enhances the Efficacy and Safety of Anticancer Drug
   Alice Njolke Mafe, Dietrich Büsselberg · 2025 · Biomedicines
10. Emerging biomarkers for neoadjuvant immune checkpoint inhibitors in operable non-small cell lung cancer
    Monika Pradhan, Mathieu Chocry, Don Lynn Gibbons, Boris Sepesi, Tina Cascone · 2021 · Translational Lung Cancer Research
11. The gut microbiome can be used to predict the gastrointestinal response and efficacy of lung cancer patients undergoing chemotherapy
    Min Zhang, Huan Zhou, Shanshan Xu, Dan Liu, Ye Cheng, Bing Xin Gao, Xiuhua Li, Jun Chen · 2020 · Annals of Palliative Medicine
12. Composition of intestinal flora affects the risk relationship between Alzheimer's disease/Parkinson's disease and cancer.
    Zhong-Ci Hang, Tong Lei, Ze-Hua Zeng, Shang-Lin Cai, Wang-Yu Bi, Hongwu Du · 2021 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
13. The Role of the Microbiome in Pancreatic Cancer
    Koji Miyabayashi, Hideaki Ijichi, Mitsuhiro Fujishiro · 2022 · Cancers
14. Exploiting dietary fibre and the gut microbiota in pelvic radiotherapy patients
    Selina E. Eaton, Justyna Kaczmarek, Daanish Mahmood, Anna M. McDiarmid, Alya N. Norarfan, Erin G. Scott, Chee Kin Then, Hailey Y. Tsui, Anne E. Kiltie · 2022 · British Journal of Cancer
15. The Lung Microbiota and Lung Cancer: A Growing Relationship
    Maroun Bou Zerdan, Joseph T. Kassab, Paul Meouchy, Elio Haroun, Rami Nehme, Morgan Bou Zerdan, Gracia Fahed, Michael Petrosino, Dibyendu Dutta, Stephen L. Graziano · 2022 · Cancers
16. Gut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy
    Yunbo He, Jinliang Huang, Qiaorong Li, Weiping Xia, Chunyu Zhang, Zhi Liu, Jiatong Xiao, Zhenglin Yi, Hao Deng, Zicheng Xiao et al. · 2022 · Cancers
17. Peptidoglycan NlpC/P60 peptidases in bacterial physiology and host interactions
    Matthew E. Griffin, Steven Klupt, Juliel Espinosa, Howard C. Hang · 2022 · Cell chemical biology
18. Colon-specific controlled release of oral liposomes for enhanced chemo-immunotherapy against colorectal cancer
    Mengya Niu, Yihan Pei, Tiantian Jin, Jun-Xiu Li, Liming Bai, Cuixia Zheng, Qingling Song, Hongjuan Zhao, Yun Zhang, Lei Wang · 2024 · Acta Pharmaceutica Sinica B
19. Save the microbes to save the planet. A call to action of the International Union of the Microbiological Societies (IUMS)
    Rino Rappuoli, Paul R. Young, Eliora Z. Ron, Simone Pecetta, Mariagrazia Pizza · 2023 · One Health Outlook
20. Investigating the causal impact of gut microbiota on glioblastoma: a bidirectional Mendelian randomization study
    Chuan Zeng, Chaolong Zhang, Chunming He, Haimin Song · 2023 · BMC Genomics
21. Role of the gut microbiota in tumorigenesis and treatment
    Qingya Liu, Yun Yang, Meng Pan, Fan Yang, Yan Yu, Zhiyong Qian · 2024 · Theranostics
22. Is it true that gut microbiota is considered as panacea in cancer therapy?
    Amir Salek Farrokhi, Narges Darabi, Bahman Yousefi, Rafee Habib Askandar, Mansoreh Shariati, Majid Eslami · 2019 · Journal of Cellular Physiology
23. What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy?
    Qingyi Wang, Bin Xie, Shuang Liu, Ying Shi, Yongguang Tao, Desheng Xiao, Wenxiang Wang · 2021 · Frontiers in Immunology
24. Analysis of Skin Marks Through the Use of Intelligent Things
    Dawid Połap · 2019 · IEEE Access
25. Antitumor effects of polysaccharides from Tetrastigma hemsleyanum Diels et Gilg via regulation of intestinal flora and enhancing immunomodulatory effects in vivo
    Fangmei Zhou, Yan Lu, Tong Sun, Ling V. Sun, Bixu Wang, Jingjing Lu, Zhimin Li, Bingqi Zhu, Shigao Huang, Zhishan Ding · 2022 · Frontiers in Immunology
26. Salivary microbiome changes distinguish response to chemoradiotherapy in patients with oral cancer
    Marcell Costa de Medeiros, Stephanie The, Emily Light Bellile, Nickole Russo, Ligia B. Schmitd, Erika B. Danella, Priyanka A. Singh, Rajat Banerjee, Christine M. Bassis, George R. Murphy et al. · 2023 · Microbiome
27. A specific enterotype derived from gut microbiome of older individuals enables favorable responses to immune checkpoint blockade therapy
    Xiaoqiang Zhu, Xiaowen Huang, Muni Hu, Rongrong Sun, Jiantao Li, Hai Wang, Xuefeng Pan, Yanru Ma, Lijun Ning, Tianying Tong et al. · 2024 · Cell Host & Microbe
28. Unraveling the gut microbiome’s contribution to pancreatic ductal adenocarcinoma: mechanistic insights and therapeutic perspectives
    Eileen Tabrizi, Fatemeh Pourteymour Fard Tabrizi, Gehad Mahmoud Khaled, Michael P. Sestito, Saeid Jamie, Brian A. Boone · 2024 · Frontiers in Immunology
29. In Vitro and In Vivo Activities of Zinc Linolenate, a Selective Antibacterial Agent against Helicobacter pylori
    Yan-Qiang Huang, Xudong Hang, Xueqing Jiang, Liping Zeng, Jia Jia, Yong Xie, Fei Yue Li, Hongkai Bi · 2019 · Antimicrobial Agents and Chemotherapy
30. Driving success in personalized medicine through AI-enabled computational modeling
    Kaushik Chakravarty, Victor G. Antontsev, Yogesh Bundey, Jyotika Varshney · 2021 · Drug Discovery Today
31. Response to PD-1-Based Immunotherapy for Non-Small Cell Lung Cancer Altered by Gut Microbiota
    Daqiang He, Xing Li, Rui An, Lihong Wang, Yun Wang, Song Zheng, Xueqing Chen, Xianjun Wang · 2021 · Oncology and Therapy
32. Commensal Intestinal Protozoa—Underestimated Members of the Gut Microbial Community
    Magdalena Dubik, Bartosz Pilecki, Jesper Bonnet Moeller · 2022 · Biology
33. Anticancer Activity of Diosgenin and Its Molecular Mechanism
    Qunli Ren, Qian Wang, Xin-Qun Zhang, Miao Wang, Huan Hu, Junjie Tang, Xiong-Tong Yang, Ying-Hui Ran, Huan‐Huan Liu, Zhi-xing Song et al. · 2023 · Chinese Journal of Integrative Medicine
34. Eubacterium rectale Improves the Efficacy of Anti-PD1 Immunotherapy in Melanoma via l -Serine-Mediated NK Cell Activation
    Nian Liu, Lihui Chen, Mingjie Yan, Qian Tao, Jie Wu, Jing Chen, Xiang Chen, Wei Zhang, Cong Peng · 2023 · Research
35. Gut microbiome model predicts response to neoadjuvant immunotherapy plus chemoradiotherapy in rectal cancer
    Zhengyang Yang, Jingxin Ma, Jiagang Han, Ang Li, Gang Liu, Yi Sun, Jianyong Zheng, Jie Zhang, Guangyong Chen, Rui‐Hua Xu et al. · 2024 · Med
36. Micro/Nanomotor‐Driven Intelligent Targeted Delivery Systems: Dynamics Sources and Frontier Applications
    Yue Yu, Ling Liang, Ting Sun, Haiying Lu, Pushan Yang, Jinrong Li, Qinjiao Pang, Jia Zeng, Ping Shi, Jianshu Li et al. · 2024 · Advanced Healthcare Materials
37. Emerging Role of Gut Microbiota in Breast Cancer Development and Its Implications in Treatment
    Rashid Mir, Shrooq Albarqi, Wed Albalawi, Hanan E. Alatwi, Marfat Alatawy, Ruqaiah I. Bedaiwi, Reema Almotairi, Eram Husain, Mohammad Zubair, Ghaida Bandar Alanazi et al. · 2024 · Metabolites
38. Dysbiosis of the gut microbiota and colorectal cancer: the key target of molecular pathological epidemiology
    Keisuke Kosumi, Kosuke Mima, Hideo Baba, Shuji Ogino · 2018 · Journal of Laboratory and Precision Medicine
39. Early Signs of Gut Microbiome Aging: Biomarkers of Inflammation, Metabolism, and Macromolecular Damage in Young Adulthood
    Audrey Renson, Kathleen Mullan Harris, Jennifer B. Dowd, Lauren M. Gaydosh, Matthew B. McQueen, Kenneth S. Krauter, Michael J. Shanahan, Allison E. Aiello · 2020 · The Journals of Gerontology Series A
40. Detection of cell-free microbial DNA using a contaminant-controlled analysis framework
    Enrique Zozaya‐Valdés, Stephen Q. Wong, Jeanette Raleigh, Athena Hatzimihalis, Sarah Ftouni, Anthony T. Papenfuss, Shahneen Kaur Sandhu, Mark A. Dawson, Sarah‐Jane Dawson · 2021 · Genome biology
41. The therapeutic and prognostic implications of immunobiology in colorectal cancer: a review
    Alexandra M. Zaborowski, Des C. Winter, Lydia Lynch · 2021 · British Journal of Cancer
42. Emerging Insights into the Impact of Air Pollution on Immune-Mediated Asthma Pathogenesis
    Jasmine A. Tuazon, Brita J. Kilburg-Basnyat, Lauren M. Oldfield, Rosana A. Wiscovitch-Russo, Katelyn Dunigan, Alexey V. Fedulov, Kenneth J. Oestreich, Kymberly M. Gowdy · 2022 · Current Allergy and Asthma Reports
43. Lactobacillus kefiranofaciens ZW18 from Kefir enhances the anti-tumor effect of anti-programmed cell death 1 (PD-1) immunotherapy by modulating the gut microbiota
    Jingqi Zhao, Yanping Wang, Jingrui Wang, Mengxin Lv, Cong Zhou, Longgang Jia, Weitao Geng · 2022 · Food & Function
44. Unveiling the intratumoral microbiota within cancer landscapes
    Shusheng Che, Zhiyong Yan, Yugong Feng, Zhao Hai · 2024 · iScience
45. Microbiome and pancreatic cancer: time to think about chemotherapy
    Juliana de Castilhos, Katharina Tillmanns, Jana Blessing, A. Larano, Vadim Borisov, Christoph K. Stein‐Thoeringer · 2024 · Gut Microbes
46. Integrative multi-omics analysis uncovers tumor-immune-gut axis influencing immunotherapy outcomes in ovarian cancer
    Spencer R. Rosario, Mark D. Long, Shanmuga Reddy Chilakapati, Eduardo Cortes Gomez, Sebastiano Battaglia, Prashant K. Singh, Jianmin Wang, Katy Wang, Kristopher M. Attwood, Suzanne M. Hess et al. · 2024 · Nature Communications
47. Microbial dysbiosis is associated with aggressive histology and adverse clinical outcome in B-cell non-Hodgkin lymphoma
    Catherine Diefenbach, Brandilyn A. Peters, Huilin Li, Bruce G. Raphael, Tibor Moskovits, Kenneth B. Hymes, Jonas Schlüter, J. Chen, N. Nora Bennani, Thomas Elmer Witzig et al. · 2021 · Blood Advances
48. Research progress on gut microbiota in patients with gastric cancer, esophageal cancer, and small intestine cancer
    Changchang Chen, Linjie Chen, Lijun Lin, Dazhi Jin, Yaoqiang Du, Jianxin Lyu · 2021 · Applied Microbiology and Biotechnology
49. The Role of Microbiota-Derived Vitamins in Immune Homeostasis and Enhancing Cancer Immunotherapy
    Hasti Gholami, John A. Chmiel, Jeremy P. Burton, Saman Maleki Vareki · 2023 · Cancers
50. Comprehensive metabolomic analysis identifies key biomarkers and modulators of immunotherapy response in NSCLC patients
    Se‐Hoon Lee, Sujeong Kim, Jueun Lee, Yunjae Kim, Yanghyun Joo, Jun-Yeong Heo, Heeyeon Lee, Charles Lee, Geum‐Sook Hwang, Hansoo Park · 2024 · Drug Resistance Updates
51. Identification of gut microbiome features associated with host metabolic health in a large population-based cohort
    Ayya Keshet, Eran Segal · 2024 · Nature Communications
52. Benefits of using probiotics as adjuvants in anticancer therapy (Review)
    Silvia Vivarelli, Luca Falzone, Maria Sofia Basile, Daria Nicolosi, Carlo Genovese, Massimo Libra, Mario Salmeri · 2019 · World Academy of Sciences Journal
53. Impact of Use of Antibiotics on Response to Immune Checkpoint Inhibitors and Tumor Microenvironment
    Uqba Khan, Kaylee Ho, Eun Kyeong Hwang, Cristian Peña, Julianna Brouwer, Katherine Hoffman, Doron Betel, Gregory F. Sonnenberg, Bishoy M. Faltas, Ashish Saxena et al. · 2021 · American Journal of Clinical Oncology
54. Gut Microbiota and Acute Diverticulitis: Role of Probiotics in Management of This Delicate Pathophysiological Balance
    Andrea Piccioni, Laura Franza, Mattia Brigida, Christian Zanza, Enrico Torelli, Martina Petrucci, Rebecca Nicolò, Marcello Covino, Marcello Candelli, Angela Saviano et al. · 2021 · Journal of Personalized Medicine
55. A Distinct Innate Immune Signature of Early Onset Colorectal Cancer
    Ivy H. Gardner, Ragavan V. Siddharthan, Katherine M. Watson, Elizabeth N. Dewey, Rebecca A. Ruhl, Sokchea Khou, Xiangnan Guan, Zheng Xia, Vassiliki Liana Tsikitis, Sudarshan Anand · 2021 · ImmunoHorizons
56. T2R bitter taste receptors regulate apoptosis and may be associated with survival in head and neck squamous cell carcinoma
    Ryan M. Carey, Derek B. McMahon, Zoey A. Miller, Tae‐Beom Kim, Karthik Rajasekaran, Indiwari Gopallawa, Jason G. Newman, Devraj Basu, Kevin Thomas Nead, Elizabeth A White et al. · 2021 · Molecular Oncology
57. Current status of intratumour microbiome in cancer and engineered exogenous microbiota as a promising therapeutic strategy
    Jiawen Chen, Ting Li, Jianhao Liang, Qiqi Huang, Jian‐Dong Huang, Yiquan Ke, Haitao Sun · 2021 · Biomedicine & Pharmacotherapy
58. Human Microbiota and Immunotherapy in Breast Cancer - A Review of Recent Developments
    Marina Miguel Vitorino, Susana Baptista de Almeida, Diogo Alpuim Costa, Ana Faria, Conceição Calhau, Sofia Azambuja Braga · 2022 · Frontiers in Oncology
59. Effects of ginsenoside compound K on colitis-associated colorectal cancer and gut microbiota profiles in mice
    Li Shao, Yinping Guo, Li Wang, Man‐Yun Chen, Wei Zhang, Sheng Deng, Weihua Huang · 2022 · Annals of Translational Medicine
60. Multi-omics of the gut microbial ecosystem in patients with microsatellite-instability-high gastrointestinal cancer resistant to immunotherapy
    Siyuan Cheng, Zihan Han, Die Dai, Fang Li, Xiaotian Zhang, Ming Shian Lu, Zhihao Lü, Xicheng Wang, Jun Zhou, Jian Li et al. · 2024 · Cell Reports Medicine
61. Gut microbiota Parabacteroides distasonis enchances the efficacy of immunotherapy for bladder cancer by activating anti-tumor immune responses
    Benlin Wang, Yifeng Qiu, Ming Xie, Pengcheng Huang, Yao Yu, Qi Sun, Wentai Shangguan, Weijia Li, Zhangrui Zhu, Jingwen Xue et al. · 2024 · BMC Microbiology
62. The greater inflammatory pathway—high clinical potential by innovative predictive, preventive, and personalized medical approach
    Maria Giovanna Maturo, Marzia Soligo, Greg C. Gibson, Luigi Manni, Christine Nardini · 2019 · The EPMA Journal
63. Microbiota Alterations and Their Association with Oncogenomic Changes in Pancreatic Cancer Patients
    Heidelinde Sammallahti, Arto Kokkola, Sama Rezasoltani, Reza Ghanbari, Hamid Asadzadeh Aghdaei, Sakari Knuutila, Pauli Antero Puolakkainen, Virinder Kaur Sarhadi · 2021 · International Journal of Molecular Sciences
64. Inflammation and infection in plasma cell disorders: how pathogens shape the fate of patients
    Jessica Caro, Marc Justin Braunstein, Louis S. Williams, Benedetto Bruno, David Kaminetzky, Ariel Siegel, Beatrice M. Razzo, Serge Alfandari, Gareth John Morgan, Faith E. Davies et al. · 2022 · Leukemia
65. High-throughput transcriptomics of 409 bacteria–drug pairs reveals drivers of gut microbiota perturbation
    Ricaurte, Deirdre, Huang, Yiming, Sheth, Ravi U., Gelsinger, Diego Rivera, Kaufman, Andrew, Wang, Harris H. · 2024 · Nature Microbiology
66. Hepatocellular Carcinoma Immunotherapy: Predictors of Response, Issues, and Challenges
    Alessandro Rizzo, Oronzo Brunetti, Giovanni Brandi · 2024 · International Journal of Molecular Sciences
67. The gut microbiome in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
    Riccardo Masetti, Daniele Zama, Davide Leardini, Edoardo Muratore, Silvia Turroni, Arcangelo Prete, Patrizia Brigidi, Andrea Pession · 2020 · Pediatric Blood & Cancer
68. The impact of antibiotics on efficacy of immune checkpoint inhibitors in malignancies: A study based on 44 cohorts
    Qing Wu, Junjin Liu, Su‐Mei Wu, Xianhe Xie · 2021 · International Immunopharmacology
69. Engraftment of Bacteria after Fecal Microbiota Transplantation Is Dependent on Both Frequency of Dosing and Duration of Preparative Antibiotic Regimen
    Vancheswaran Gopalakrishnan, Elizabeth Ashley Dozier, Matthew S. Glover, Steven J. Novick, Michael W Ford, Christopher A. Morehouse, Paul Warrener, Carolina S. Caceres, Sonja Y. Hess, Bret R. Sellman et al. · 2021 · Microorganisms
70. Safety assessment of crude saponins from Chenopodium quinoa willd. husks: 90-day oral toxicity and gut microbiota & metabonomics study in rats
    Ruoyu Zhang, Qingfeng Zhai, Yuan Yu, Xuening Li, Fengxiang Zhang, Zhaohua Hou, Yuqing Cao, Jing Feng, Peng Xue · 2021 · Food Chemistry
71. Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma
    Ambreen Muhammed, Antonio D’Alessio, Andrei Enica, THOMAS L. TALBOT, Claudia Angela Maria Fulgenzi, Georgios Nteliopoulos, Robert David Goldin, Alessio Cortellini, David James Pinato · 2022 · Expert Review of Molecular Diagnostics
72. Altered Salivary Microbiota in Patients with Obstructive Sleep Apnea Comorbid Hypertension
    Xuehui Chen, Yanlong Chen, Mengqi Feng, Xin Huang, Changtao Li, Fang Han, Qian Zhang, Xuemei Gao · 2022 · Nature and Science of Sleep
73. Research Progress on the Anticancer Activities and Mechanisms of Polysaccharides From Ganoderma
    Man Wang, Fei Yu · 2022 · Frontiers in Pharmacology
74. Intratumor microbiome: selective colonization in the tumor microenvironment and a vital regulator of tumor biology
    Mingjie Jiang, Zhongyuan Yang, Juanjuan Dai, Tong Wu, Zan Jiao, Yongchao Yu, Ning Kang, Weichao Chen, Ankui Yang · 2023 · MedComm
75. Host–MicroRNA–Microbiota Interactions in Colorectal Cancer
    Ce Yuan, Clifford J. Steer, Subbaya Subramanian · 2019 · Genes
76. The gut mycobiome: The overlooked constituent of clinical outcomes and treatment complications in patients with cancer and other immunosuppressive conditions
    Jessica Galloway-Peña, Dimitrios P. Kontoyiannis · 2020 · PLoS Pathogens
77. The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives
    Lina Elsalem, Ahmad A. Jum’ah, Mahmoud A. Alfaqih, Osama Aloudat · 2020 · Clinical and Experimental Gastroenterology
78. Comparative Analysis of Age- and Gender-Associated Microbiome in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
    Lindsay M. Wong, Neil Shende, Wei Tse Li, Grant Castaneda, Lauren Apostol, Eric Yao Chang, Weg M. Ongkeko · 2020 · Cancers
79. Unsaturated alginate oligosaccharides (UAOS) protects against dextran sulfate sodium-induced colitis associated with regulation of gut microbiota
    Ningning He, Yue Yang, Haoyu Wang, Nian Liu, Zizhen Yang, Shangyong Li · 2021 · Journal of Functional Foods
80. The association between proton pump inhibitors use and clinical outcome of patients receiving immune checkpoint inhibitors therapy
    Manyu Li, Chaofan Zeng, Jiannan Yao, Yang Ge, Guangyu An · 2020 · International Immunopharmacology
81. Impact of enteral immunonutrition on infectious complications and immune and inflammatory markers in cancer patients undergoing chemotherapy: A systematic review of randomised controlled trials
    Laura J. Miller, Cara Douglas, Fiona S.W. McCullough, Simon J. Stanworth, Philip C. Calder · 2022 · Clinical Nutrition
82. Potential Ability of Probiotics in the Prevention and Treatment of Colorectal Cancer
    Jiahao Zhao, Yiqun Liao, Chen Wei, Yichao Ma, Fei Wang, Yuji Chen, Bin Zhao, Hao Ji, Daorong Wang, Dong Tang · 2023 · Clinical Medicine Insights Oncology
83. Lacking Immunotherapy Biomarkers for Biliary Tract Cancer: A Comprehensive Systematic Literature Review and Meta-Analysis
    Giorgio Frega, Fernando Pedro Cossío, Jesús M. Bañales, Vincenzo Cardinale, Rocı́o I.R. Macı́as, Chiara Braconi, Ángela Lamarca · 2023 · Cells
84. The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome
    Xiaoyu Xue, Rui Li, Zhenni Chen, Guiyu Li, Bisheng Liu, Shanshan Guo, Qianhua Yue, Siye Yang, Linlin Xie, Yiguan Zhang et al. · 2023 · Frontiers in Immunology
85. Alterations in gut and genital microbiota associated with gynecological diseases: a systematic review and meta-analysis
    Ziwei Zhou, Yifei Feng, Lishan Xie, Song Ma, Zhaoxia Cai, Ying Ma · 2024 · Reproductive Biology and Endocrinology
86. Microbiota: Overview and Implication in Immunotherapy-Based Cancer Treatments
    Giovanni Brandi, Giorgio Frega · 2019 · International Journal of Molecular Sciences
87. Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee
    Brian Gastman, Piyush Kumar Agarwal, Adam Berger, Genevieve Marie Boland, Stephen Broderick, Lisa Helene Butterfield, David R. Byrd, Peter Edward Fecci, Robert Louis Ferris, Yuman Fong et al. · 2020 · Journal for ImmunoTherapy of Cancer
88. Antibiotic-Related Changes in Microbiome: The Hidden Villain behind Colorectal Carcinoma Immunotherapy Failure
    Tsvetelina Veselinova Velikova, Boris Milev Krastev, Stefan Lozenov, Radostina Gencheva, Monika Peshevska-Sekulovska, Georgi Nikolaev, Milena Peruhova · 2021 · International Journal of Molecular Sciences
89. Overcoming Resistance to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinomas
    Lucas Vieira dos Santos, Carina Meira Abrahão, William N. William · 2021 · Frontiers in Oncology
90. Focus on the Complex Interconnection between Cancer, Narcolepsy and Other Neurodegenerative Diseases: A Possible Case of Orexin-Dependent Inverse Comorbidity
    Maria Paola Mogavero, Alessandro Silvani, Lourdes M. DelRosso, Michele Salemi, Raffaele Ferri · 2021 · Cancers
91. Proton Pump Inhibitors and Cancer: Current State of Play
    Marie Bridoux, Nicolas Simon, Anthony Turpin · 2022 · Frontiers in Pharmacology
92. Role of microbiome and its metabolite, short chain fatty acid in prostate cancer
    Hee Jo Yang, Jae Heon Kim · 2023 · Korean journal of urology
93. Context-Dependent Regulation of Type17 Immunity by Microbiota at the Intestinal Barrier
    Begum Akuzum, June‐Yong Lee · 2022 · Immune Network
94. Nanocatalytic Anti‐Tumor Immune Regulation
    Mingyuan Li, Han Jiang, Ping Hu, Jianlin Shi · 2024 · Angewandte Chemie International Edition
95. Exploring the Role of the Gut Microbiota in Modulating Colorectal Cancer Immunity
    Nikolay K. Shakhpazyan, Л.М. Михалева, Arcady L. Bedzhanyan, Гиоева Зарина Владиславовна, Alexander I. Mikhalev, Konstantin Yu. Midiber, Valentina V. Pechnikova, Andrey E. Biryukov · 2024 · Cells
96. Mapping pesticide-induced metabolic alterations in human gut bacteria
    Li Chen, Hongbin Yan, Shanshan Di, Chao Guo, Huan Zhang, Shiqi Zhang, Andrew Gold, Yu Wang, Ming Hu, Dayong Wu et al. · 2025 · Nature Communications
97. Gut microbiota mediated molecular events and therapy in liver diseases
    Xiaoqiang Qi, Ming Jun Yang, Joseph Stenberg, Rahul Dey, Leslie Fogwe, Muhammad Shawkat Alam, Eric T. Kimchi, Kevin F. Staveley-O’Carroll, Guangfu Li · 2020 · World Journal of Gastroenterology
98. Therapeutic approaches to colorectal cancer via strategies based on modulation of gut microbiota
    Maohua Chen, Wei Lin, Nan Li, Qian Wang, Shaomi Zhu, Anqi Zeng, Linjiang Song · 2022 · Frontiers in Microbiology
99. Microbiome influencers of checkpoint blockade–associated toxicity
    Yinghong Wang, Robert R. Jenq, Jennifer Ann Wargo, Stephanie S. Watowich · 2023 · The Journal of Experimental Medicine
100. Immunological consequences of microbiome-based therapeutics
     Md. Zahidul Alam, Jeffrey R. Maslanka, Michael C. Abt · 2023 · Frontiers in Immunology